NCT01428297View on ClinicalTrials.gov

A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Healthy VolunteersAtopic DermatitisNetherton Syndrome
Interventions
DRUG

BPR277 ointment (controlled application)

DRUG

Placebo (Vehicle)

DRUG

BPR277 ointment

DRUG

Placebo (Vehicle)

DRUG

BPR277

DRUG

Placebo (Vehicle)

Trial Locations (4)

58104

Novartis Investigative Site, Fargo

63104

Novartis Investigative Site, St Louis

06519

Novartis Investigative Site, New Haven

3508 GA

Novartis Investigative Site, Utrecht

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY